Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Screening potential anti-osteoarthritis compounds using molecular docking based on MAPK and NFκB pathways and validating their anti-osteoarthritis effect

  • Tian-Wang Zhu,
  • Yu Zheng,
  • Rui-Xin Li

The caption for Fig 1 is incorrect. Please see the correct Fig 1 caption here.

Fig 1. The roles of the MAPK and NFκB pathways in the onset and progression of osteoarthritis.

The following information should have been the last paragraph of Introduction section: Molecular docking is a powerful computational technique used to simulate the interaction between a compound and a protein to evaluate their binding potential. As a strong competitor to high-throughput omics, this technique has been widely used in drug discovery [10]. However, to our knowledge, no studies focused on screening anti-osteoarthritis compounds using molecular docking. This study aimed to screen potential anti-osteoarthritis compounds by docking with core human proteins in the MAPK and NFκB pathways, analyze their drug-likeness, pharmacokinetics, bioactivity, and toxicity, and test their cytotoxicity and anti-osteoarthritis effect on mouse chondrocytes.

Reference

  1. 1. Zhu T-W, Zheng Y, Li R-X. Screening potential anti-osteoarthritis compounds using molecular docking based on MAPK and NFκB pathways and validating their anti-osteoarthritis effect. PLoS One. 2025;20(3): e0319686. pmid:40131994